Simon Grieveson, assistant director of research at Prostate Cancer UK, said: “With over 12,000 men dying from prostate cancer each year in the UK, we urgently need new and innovative ways to treat the disease. Immunotherapy has shown huge benefits to patients in several other cancers, but to date it has not had the same impact in prostate cancer.
